462 related articles for article (PubMed ID: 20174468)
1. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.
Crews L; Spencer B; Desplats P; Patrick C; Paulino A; Rockenstein E; Hansen L; Adame A; Galasko D; Masliah E
PLoS One; 2010 Feb; 5(2):e9313. PubMed ID: 20174468
[TBL] [Abstract][Full Text] [Related]
2. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.
Spencer B; Potkar R; Trejo M; Rockenstein E; Patrick C; Gindi R; Adame A; Wyss-Coray T; Masliah E
J Neurosci; 2009 Oct; 29(43):13578-88. PubMed ID: 19864570
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
Rockenstein E; Nuber S; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Trejo-Morales M; Gerez J; Picotti P; Jensen PH; Campioni S; Riek R; Winkler J; Gage FH; Winner B; Masliah E
Brain; 2014 May; 137(Pt 5):1496-513. PubMed ID: 24662516
[TBL] [Abstract][Full Text] [Related]
4. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.
Price DL; Rockenstein E; Ubhi K; Phung V; MacLean-Lewis N; Askay D; Cartier A; Spencer B; Patrick C; Desplats P; Ellisman MH; Masliah E
PLoS One; 2010 Nov; 5(11):e14020. PubMed ID: 21103359
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients.
Evans T; Kok WL; Cowan K; Hefford M; Anichtchik O
Brain Res; 2018 Feb; 1681():1-13. PubMed ID: 29278715
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation.
Kim C; Spencer B; Rockenstein E; Yamakado H; Mante M; Adame A; Fields JA; Masliah D; Iba M; Lee HJ; Rissman RA; Lee SJ; Masliah E
Mol Neurodegener; 2018 Aug; 13(1):43. PubMed ID: 30092810
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models.
Iba M; Kim C; Sallin M; Kwon S; Verma A; Overk C; Rissman RA; Sen R; Sen JM; Masliah E
J Neuroinflammation; 2020 Jul; 17(1):214. PubMed ID: 32680537
[TBL] [Abstract][Full Text] [Related]
10. Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission.
Bae EJ; Lee HJ; Rockenstein E; Ho DH; Park EB; Yang NY; Desplats P; Masliah E; Lee SJ
J Neurosci; 2012 Sep; 32(39):13454-69. PubMed ID: 23015436
[TBL] [Abstract][Full Text] [Related]
11. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G; Schlüter OM; Südhof TC
Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology.
Ngolab J; Trinh I; Rockenstein E; Mante M; Florio J; Trejo M; Masliah D; Adame A; Masliah E; Rissman RA
Acta Neuropathol Commun; 2017 Jun; 5(1):46. PubMed ID: 28599681
[TBL] [Abstract][Full Text] [Related]
13. Autophagy mediators (FOXO1, SESN3 and TSC2) in Lewy body disease and aging.
Miki Y; Tanji K; Mori F; Utsumi J; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
Neurosci Lett; 2018 Sep; 684():35-41. PubMed ID: 29966750
[TBL] [Abstract][Full Text] [Related]
14. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
[TBL] [Abstract][Full Text] [Related]
15. Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies.
Higashi S; Moore DJ; Minegishi M; Kasanuki K; Fujishiro H; Kabuta T; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H; Wada K; Iseki E
J Neuropathol Exp Neurol; 2011 Apr; 70(4):264-80. PubMed ID: 21412173
[TBL] [Abstract][Full Text] [Related]
16. Pathology-associated change in levels and localization of SIDT2 in postmortem brains of Parkinson's disease and dementia with Lewy bodies patients.
Fujiwara Y; Kabuta C; Sano T; Murayama S; Saito Y; Kabuta T
Neurochem Int; 2022 Jan; 152():105243. PubMed ID: 34800582
[TBL] [Abstract][Full Text] [Related]
17. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
Yan R; Zhang J; Park HJ; Park ES; Oh S; Zheng H; Junn E; Voronkov M; Stock JB; Mouradian MM
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E12053-E12062. PubMed ID: 30509990
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies.
Campbell BC; Li QX; Culvenor JG; Jäkälä P; Cappai R; Beyreuther K; Masters CL; McLean CA
Neurobiol Dis; 2000 Jun; 7(3):192-200. PubMed ID: 10860784
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1.
Miners JS; Renfrew R; Swirski M; Love S
Acta Neuropathol Commun; 2014 Dec; 2():164. PubMed ID: 25476568
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBD.
Spencer B; Michael S; Shen J; Kosberg K; Rockenstein E; Patrick C; Adame A; Masliah E
Mol Ther; 2013 Jan; 21(1):31-41. PubMed ID: 22508489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
